8TH ANNUAL AFRICAN VACCINOLOGY COURSE, CAPE TOWN, ...
Dear Vaccine Colleagues, The Vaccines for Africa Initiative (www.vacfa.com) will organise the 8th Annual African Vaccinology Course in Cape Town, South Africa, from 05 November to 08 November 2012. The course is intended for EPI managers, medical do ... read moreHPV SAFETY AND EFFICACY
HPV EFFICACY Full text is at http://www.biomedcentral.com/1471-2334/11/13 Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis Beibei Lu1, ... read moreA HUMAN CHALLENGE MODEL FOR M. TUBERCULOSIS
'large-scale and very costly trials will be needed to determine the efficacy of a new tuberculosis vaccine. The development of these vaccines is hampered by our current inability to identify biosignatures or correlates of protection that would ... read moreHUMAN PAPILLOMAVIRUS VACCINE DELIVERY STRATEGIES
[source]http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209730/?tool=pubmed[|source]Bull World Health Organ. 2011 Nov 1;89(11):821-830B. HUMAN PAPILLOMAVIRUS VACCINE DELIVERY STRATEGIES Full text is at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC ... read moreGREATEST HITS IN NEW VACCINES
GREATEST HITS IN NEW VACCINES Dear All, Since 2008, 23 items on new and underused vaccines (pneumococcal, rotavirus and HPV) have attracted more than 100 page views on the part of you, my readers. Here they are, in descending order by n ... read morePUBLIC-PRIVATE COLLABORATION IN VACCINE RESEARCH
PUBLIC—PRIVATE COLLABORATION IN VACCINE RESEARCH Original Text Juhani Eskola a , Terhi Kilpi a Also at http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60690-9/fulltext See also http://www.ncbi.nlm.nih.g ... read moreCHALLENGES AND OPPORTUNITIES IN TUBERCULOSIS RESEA ...
VIEWPOINT: CHALLENGES AND OPPORTUNITIES IN TUBERCULOSIS RESEARCH J Infect Dis. (2012) 1. Peter S. Kim1, Mamodikoe Makhene2, Christine Sizemore2 and Richard Hafner1 + Author Affiliations 1.&nb ... read morePUBLIC-PRIVATE COLLABORATION IN VACCINE RESEARCH
PUBLIC—PRIVATE COLLABORATION IN VACCINE RESEARCH Original Text Juhani Eskola a , Terhi Kilpi a Also at http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60690-9/fulltext See also http://www.ncbi.n ... read moreAre three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41102905 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |